Clinical Trial Update: Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating the efficacy of vildagliptin versus metformin for polycystic ovary syndrome and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Vildagliptin (vildagliptin)
• metformin (metformin)

Snippet

Sponsor: October 6 University | Conditions: Poly Cystic Ovary Syndrome | Phase 2, Phase 3 | Status: RECRUITING